ME Therapeutics Holdings Inc.
METX
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.65% | -8.54% | 22.15% | 253.06% | -41.18% |
| Total Receivables | 54.47% | 28.13% | 62.71% | -74.12% | 330.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 221.93% | 648.00% | -57.63% | -86.18% | 233.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.02% | -6.92% | 21.92% | 189.68% | -30.11% |
|
|
|||||
| Total Current Assets | -10.02% | -6.92% | 21.92% | 189.68% | -30.11% |
| Net Property, Plant & Equipment | 79,700.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.34% | -6.91% | 21.92% | 189.62% | -30.10% |
|
|
|||||
| Total Accounts Payable | 88.30% | 238.61% | -- | -- | -65.36% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 0.00% |
| Total Finance Division Other Current Liabilities | -- | 359.26% | -- | -- | -92.31% |
| Total Other Current Liabilities | -- | 359.26% | -- | -- | -92.31% |
| Total Current Liabilities | 169.10% | 35.86% | -- | -- | -47.22% |
|
|
|||||
| Total Current Liabilities | 169.10% | 35.86% | -- | -- | -47.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 257.08% | 35.86% | -- | -- | -47.22% |
|
|
|||||
| Common Stock & APIC | -3.68% | 1.10% | 33.42% | 0.74% | -0.27% |
| Retained Earnings | 0.28% | -4.94% | -5.86% | -1.90% | -4.46% |
| Treasury Stock & Other | 0.09% | 5.53% | -18.03% | 31.34% | 6.26% |
| Total Common Equity | -13.40% | -8.15% | 18.50% | 247.65% | -25.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.40% | -8.15% | 18.50% | 247.65% | -25.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.40% | -8.15% | 18.50% | 247.65% | -25.25% |
|
|
|||||
